Literature DB >> 18174467

The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.

Weifei Zhu1, Sonika Saddar, Divya Seetharam, Ken L Chambliss, Christopher Longoria, David L Silver, Ivan S Yuhanna, Philip W Shaul, Chieko Mineo.   

Abstract

Circulating levels of high-density lipoprotein (HDL) cholesterol are inversely related to the risk of cardiovascular disease, and HDL and the HDL receptor scavenger receptor class B type I (SR-BI) initiate signaling in endothelium through src that promotes endothelial NO synthase activity and cell migration. Such signaling requires the C-terminal PDZ-interacting domain of SR-BI. Here we show that the PDZ domain-containing protein PDZK1 is expressed in endothelium and required for HDL activation of endothelial NO synthase and cell migration; in contrast, endothelial cell responses to other stimuli, including vascular endothelial growth factor, are PDZK1-independent. Coimmunoprecipitation experiments reveal that Src interacts with SR-BI, and this process is PDZK1-independent. PDZK1 also does not regulate SR-BI abundance or plasma membrane localization in endothelium or HDL binding or cholesterol efflux. Alternatively, PDZK1 is required for HDL/SR-BI to induce Src phosphorylation. Paralleling the in vitro findings, carotid artery reendothelialization following perivascular electric injury is absent in PDZK1-/- mice, and this phenotype persists in PDZK1-/- mice with genetic reconstitution of PDZK1 expression in liver, where PDZK1 modifies SR-BI abundance. Thus, PDZK1 is uniquely required for HDL/SR-BI signaling in endothelium, and through these mechanisms, it is critically involved in the maintenance of endothelial monolayer integrity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174467     DOI: 10.1161/CIRCRESAHA.107.159079

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

1.  Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function.

Authors:  Nathan C Sundgren; Weifei Zhu; Ivan S Yuhanna; Ken L Chambliss; Mohamed Ahmed; Keiji Tanigaki; Michihisa Umetani; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2011-09-22       Impact factor: 17.367

2.  Rare copy number variants disrupt genes regulating vascular smooth muscle cell adhesion and contractility in sporadic thoracic aortic aneurysms and dissections.

Authors:  Siddharth K Prakash; Scott A LeMaire; Dong-Chuan Guo; Ludivine Russell; Ellen S Regalado; Hossein Golabbakhsh; Ralph J Johnson; Hazim J Safi; Anthony L Estrera; Joseph S Coselli; Molly S Bray; Suzanne M Leal; Dianna M Milewicz; John W Belmont
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

3.  C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Authors:  Keiji Tanigaki; Chieko Mineo; Ivan S Yuhanna; Ken L Chambliss; Michael J Quon; Ezio Bonvini; Philip W Shaul
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

4.  Noncanonical role of the PDZ4 domain of the adaptor protein PDZK1 in the regulation of the hepatic high density lipoprotein receptor scavenger receptor class B, type I (SR-BI).

Authors:  Kosuke Tsukamoto; Thomas E Wales; Kathleen Daniels; Rinku Pal; Ren Sheng; Wonhwa Cho; Walter Stafford; John R Engen; Monty Krieger; Olivier Kocher
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

Review 5.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

Review 6.  Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.

Authors:  Wen-Jun Shen; Jie Hu; Zhigang Hu; Fredric B Kraemer; Salman Azhar
Journal:  Metabolism       Date:  2014-03-21       Impact factor: 8.694

7.  HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanisms.

Authors:  Benjamin Emert; Yehudit Hasin-Brumshtein; James R Springstead; Ladan Vakili; Judith A Berliner; Aldons J Lusis
Journal:  J Lipid Res       Date:  2014-05-23       Impact factor: 5.922

Review 8.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

9.  Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease.

Authors:  Rinku Pal; Qingen Ke; German A Pihan; Ayce Yesilaltay; Marsha L Penman; Li Wang; Chandramohan Chitraju; Peter M Kang; Monty Krieger; Olivier Kocher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

10.  Mechanism and role of high density lipoprotein-induced activation of AMP-activated protein kinase in endothelial cells.

Authors:  Takao Kimura; Hideaki Tomura; Koichi Sato; Masaaki Ito; Isao Matsuoka; Doon-Soon Im; Atsushi Kuwabara; Chihiro Mogi; Hiroshi Itoh; Hitoshi Kurose; Masami Murakami; Fumikazu Okajima
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.